Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin

被引：0
|
作者：
机构：
来源：
| 1600年 / American Assoc for the Advancement of Science, Washington, DC, USA卷 / 270期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] THE CYCLIN-DEPENDENT KINASE 2 (CDK2) IS DISPENSABLE FOR LIVER REGENERATION IN MICE AND CAN BE SUBSTITUTED BY CYCLIN D-DEPENDENT KINASE ACTIVITY AND KINASE-INDEPENDENT FUNCTIONS OF CYCLIN E
    Hu, Wei
    Nevzorova, Yulia
    Haas, Ute
    Barbacid, Mariano
    Trautwein, Christian
    Liedtke, Christian
    HEPATOLOGY, 2010, 52 (04) : 392A - 392A
  • [22] Cyclin-dependent kinase activity is required for progesterone receptor function: Novel role for cyclin A/Cdk2 as a progesterone receptor coactivator
    Narayanan, R
    Adigun, AA
    Edwards, DP
    Weigel, NL
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (01) : 264 - 277
  • [23] Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception
    Faber, Erik B.
    Wang, Nan
    Georg, Gunda, I
    BIOLOGY OF REPRODUCTION, 2020, 103 (02) : 357 - 367
  • [24] RECONSTITUTION OF CYCLIN-DEPENDENT CDC2 AND CDK2 KINASE-ACTIVITIES IN-VITRO
    PAN, ZQ
    HURWITZ, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (27) : 20433 - 20442
  • [25] Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia
    Said, TK
    Moraes, RCB
    Singh, U
    Kittrell, FS
    Medina, D
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (06): : 285 - 295
  • [26] Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
    Saqub, Hera
    Proetsch-Gugerbauer, Hannah
    Bezrookove, Vladimir
    Nosrati, Mehdi
    Vaquero, Edith M.
    de Semir, David
    Ice, Ryan J.
    McAllister, Sean
    Soroceanu, Liliana
    Kashani-Sabet, Mohammed
    Osorio, Robert
    Dar, Altaf A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Phosphorylation of MCM3 Protein by Cyclin E/Cyclin-dependent Kinase 2 (Cdk2) Regulates Its Function in Cell Cycle
    Li, Junhui
    Deng, Min
    Wei, Qian
    Liu, Ting
    Tong, Xiaomei
    Ye, Xin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (46) : 39776 - 39785
  • [28] Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
    Wee, S.
    Ye, M.
    Lo, Y.
    Hansbury, M.
    Shin, N.
    Weber, M.
    Roman, V.
    Huo, L.
    Skaggs, H.
    Drake, K.
    Kapilashrami, K.
    Stump, K.
    Yang, J.
    Chand, S.
    Timmers, C.
    Hummel, J.
    Ye, Y.
    Zhang, G.
    Yang, Y. O.
    Covington, M.
    Wu, L.
    Koblish, H.
    Kim, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S79 - S79
  • [29] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Rossi, KA
    Markwalder, JA
    Seitz, SP
    Chang, CH
    Cox, S
    Boisclair, MD
    Brizuela, L
    Brenner, SL
    Stouten, PFW
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (02) : 111 - 122
  • [30] Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
    Hera Saqub
    Hannah Proetsch-Gugerbauer
    Vladimir Bezrookove
    Mehdi Nosrati
    Edith M. Vaquero
    David de Semir
    Ryan J. Ice
    Sean McAllister
    Liliana Soroceanu
    Mohammed Kashani-Sabet
    Robert Osorio
    Altaf A. Dar
    Scientific Reports, 10
12345